Login / Signup

Optimal biologics for juvenile idiopathic arthritis in an infection with SARS-CoV-2 α-variant.

Shunichi AdachiMotoshi SonodaMasataka IshimuraKatsuhide EguchiTamami TanakaYoshitomo MotomuraShouichi Ohga
Published in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2021)
Keyphrases
  • juvenile idiopathic arthritis
  • sars cov
  • disease activity
  • respiratory syndrome coronavirus
  • systemic lupus erythematosus
  • coronavirus disease